Zahra R, Furqan M, Ullah R, Mithani A, Saleem R, Faisal A
PLoS One. 2020; 15(6):e0233993.
PMID: 32484843
PMC: 7266297.
DOI: 10.1371/journal.pone.0233993.
Robb T, Reid G, Blenkiron C
Target Oncol. 2017; 12(2):163-178.
PMID: 28138797
DOI: 10.1007/s11523-017-0476-7.
Takahashi R, Miyazaki H, Ochiya T
Cancers (Basel). 2015; 7(2):598-616.
PMID: 25860815
PMC: 4491673.
DOI: 10.3390/cancers7020598.
Mahjoubi F, Hill R, Peters G
Chromosome Res. 2006; 14(3):263-76.
PMID: 16628497
DOI: 10.1007/s10577-006-1042-9.
Wood L, Palmer M, Hewitt J, Urtasun R, Bruera E, Rapp E
Br J Cancer. 1998; 77(4):627-31.
PMID: 9484821
PMC: 2149923.
DOI: 10.1038/bjc.1998.100.
Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?.
Campling B, Baer K, BAKER H, Lam Y, Cole S
Br J Cancer. 1993; 68(2):327-35.
PMID: 8102244
PMC: 1968549.
DOI: 10.1038/bjc.1993.336.
Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines.
Jensen P, Christensen I, Sehested M, Hansen H, Vindelov L
Br J Cancer. 1993; 67(2):311-20.
PMID: 8094293
PMC: 1968190.
DOI: 10.1038/bjc.1993.58.
Human cell lines as models for multidrug resistance in solid tumours.
Clynes M, Heenan M, Hall K
Cytotechnology. 1993; 12(1-3):231-56.
PMID: 7765327
DOI: 10.1007/BF00744666.
Non-P-glycoprotein-mediated multidrug resistance with reduced EGF receptor expression in a human large cell lung cancer cell line.
Reeve J, Rabbitts P, Twentyman P
Br J Cancer. 1990; 61(6):851-5.
PMID: 1973619
PMC: 1971670.
DOI: 10.1038/bjc.1990.190.
Detection of multidrug resistance and quantification of responses of human tumour cells to cytotoxic agents using flow cytometric spectral shift analysis of Hoechst 33,342-DNA fluorescence.
Smith P, Morgan S, Watson J
Cancer Chemother Pharmacol. 1991; 27(6):445-50.
PMID: 1849464
DOI: 10.1007/BF00685158.
Chemosensitisation of a drug-sensitive parental cell line by low-dose cyclosporin A.
Twentyman P, Wright K
Cancer Chemother Pharmacol. 1991; 29(1):24-8.
PMID: 1742845
DOI: 10.1007/BF00686331.
Multidrug resistance-associated antigens on drug-sensitive and -resistant human tumour cell lines.
Mirski S, Cole S
Br J Cancer. 1991; 64(1):15-22.
PMID: 1677258
PMC: 1977290.
DOI: 10.1038/bjc.1991.232.
Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.
Coley H, Workman P, Twentyman P
Br J Cancer. 1991; 63(3):351-7.
PMID: 1672252
PMC: 1971875.
DOI: 10.1038/bjc.1991.84.
Pleiotropic-resistant phenotype is a multifactorial phenomenon in human colon carcinoma cell lines.
Toffoli G, Viel A, Tumiotto L, Biscontin G, Rossi C, Boiocchi M
Br J Cancer. 1991; 63(1):51-6.
PMID: 1671208
PMC: 1971628.
DOI: 10.1038/bjc.1991.11.
Differential recognition of mdr1a and mdr1b gene products in multidrug resistant mouse tumour cell lines by different monoclonal antibodies.
Barrand M, Twentyman P
Br J Cancer. 1992; 65(2):239-45.
PMID: 1346747
PMC: 1977717.
DOI: 10.1038/bjc.1992.48.
Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitro.
Twentyman P, Wright K, Wallace H
Br J Cancer. 1992; 65(3):335-40.
PMID: 1313690
PMC: 1977618.
DOI: 10.1038/bjc.1992.68.